Good evening all
I was wondering if I could take a considered approach to Pars future prospects. I am a long time holder and will continue to be BUT I would be interested in a well thought out worse case scenario for par shares moving forward.
Based on the phase 2 clinical trials, and if those results/data continue to phase 3 then it should get approval.
But how bad would the results have to be to get knocked back at phase 3?
Would be interested in the masses view points?
disclaimer. Long time lurker. First time poster.
Worst Case Consideration
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |